These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

11353 related items for PubMed ID: 12014627

  • 1. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice.
    Warren P, Song W, Holle E, Holmes L, Wei Y, Li J, Wagner T, Yu X.
    Anticancer Res; 2002; 22(2A):599-604. PubMed ID: 12014627
    [Abstract] [Full Text] [Related]

  • 2. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD.
    Cancer Res; 2002 Nov 15; 62(22):6545-51. PubMed ID: 12438249
    [Abstract] [Full Text] [Related]

  • 3. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
    Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ.
    Cancer Res; 2001 Mar 01; 61(5):2062-70. PubMed ID: 11280767
    [Abstract] [Full Text] [Related]

  • 4. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ, Sanford MA, Atkinson G, Chen SH.
    Cancer Res; 1998 Aug 01; 58(15):3221-5. PubMed ID: 9699645
    [Abstract] [Full Text] [Related]

  • 5. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E, Kawano K, Hattori Y, Fukushima M, Hayashi K, Maitani Y.
    J Control Release; 2007 Jul 16; 120(1-2):104-10. PubMed ID: 17509714
    [Abstract] [Full Text] [Related]

  • 6. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Jul 16; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Combination therapy of murine liver cancer with IL-12 gene and HSV-TK gene].
    Tang Z, Sun W, Chen S.
    Zhonghua Zhong Liu Za Zhi; 1999 Sep 16; 21(5):332-5. PubMed ID: 11776567
    [Abstract] [Full Text] [Related]

  • 12. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
    Wang X, Li L, Feng K, Bai L, Pei X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec 16; 21(12):628-31. PubMed ID: 11877036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
    Hanari N, Matsubara H, Hoshino I, Akutsu Y, Nishimori T, Murakami K, Sakata H, Miyazawa Y, Ochiai T.
    Anticancer Res; 2007 Dec 16; 27(4B):2305-10. PubMed ID: 17695518
    [Abstract] [Full Text] [Related]

  • 15. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL.
    Vaccine; 2004 Jul 29; 22(21-22):2894-903. PubMed ID: 15246626
    [Abstract] [Full Text] [Related]

  • 20. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar 29; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 568.